Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort.

Date publication

juin 2026

Journal

Breast cancer research : BCR

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie

Tous les auteurs :
Vignot S, Drouet Y, Di Meglio A, Martin AL, Gaudin C, Bertaut A, Fournier M, Jacot W, Cheymol C, Kieffer A, Tarpin C, Lerebours F, Caux C, Boyault S, Ménétrier-Caux C, Trédan O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/42265714

Résumé

Lymphopenia has been associated with poor outcomes in metastatic breast cancer (BC), but its prognostic relevance in early-stage disease remains unclear. This study aimed to evaluate the prognostic value of baseline lymphopenia in patients with non-metastatic BC using data from the prospective French CANTO cohort (NCT01993498).

Mots clés

Early Breast cancer, Lymphopenia, Prognosis, Relapse risk

Référence

Breast Cancer Res. 2026 06 9;: